You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced or metastatic urothelial cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 27, 2023

    Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

    Not yet recruiting
    • Advanced or Metastatic Urothelium Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Feb 22, 2023

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Avelumab in Real-World Treatment for Advanced or Metastatic

    Not yet recruiting
    • Bladder Cancer
    • (no location specified)
    Nov 21, 2022

    Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

    Not yet recruiting
    • Urothelial Carcinoma
    • Metastatic Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 28, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

    Recruiting
    • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
    • +3 more
    • Cabozantinib S-malate
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 8, 2022

    Urothelial Cancer Trial (pembrolizumab)

    Completed
    Has Results
    • Urothelial Cancer
    • pembrolizumab
    • (no location specified)
    Aug 18, 2022

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

    Recruiting
    • Advanced Urothelial Carcinoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jun 28, 2022

    Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • disitamab vedotin
    • +4 more
    • (no location specified)
    Jun 9, 2023

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

    Recruiting
    • Locally Advanced Renal Pelvis Urothelial Carcinoma
    • +20 more
    • Duarte, California
    • +16 more
    Aug 10, 2022

    Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

    Recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 8, 2023

    Metastatic Urothelial Cancer Trial in China (Enfortumab vedotin)

    Active, not recruiting
    • Metastatic Urothelial Cancer
    • Enfortumab vedotin
    • Beijing, China
    • +7 more
    Aug 23, 2022

    Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

    Recruiting
    • Urothelial Cancer
    • Huelva, Andalucia, Spain
    • +11 more
    Dec 1, 2022

    Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

    Recruiting
    • Metastatic Urothelial Carcinoma
    • Bladder Cancer
    • Tampa, Florida
    • +2 more
    Jun 9, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

    Active, not recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +35 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
    • +7 more
    Jan 3, 2023

    Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

    Recruiting
    • Advanced and Metastatic Urothelial Cancer
    • futibatinib and pembrolizumab
    • San Francisco, California
    • +17 more
    Oct 25, 2022

    Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

    Terminated
    • Urothelial Carcinoma
    • Phoenix, Arizona
    • +7 more
    Dec 15, 2022